171 related articles for article (PubMed ID: 21766386)
1. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study.
Olesen JB; Abildstrøm SZ; Erdal J; Gislason GH; Weeke P; Andersson C; Torp-Pedersen C; Hansen PR
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):964-71. PubMed ID: 21766386
[TBL] [Abstract][Full Text] [Related]
2. Comparative stroke risk of antiepileptic drugs in patients with epilepsy.
Hsieh CY; Lai EC; Yang YH; Lin SJ
Epilepsia; 2013 Jan; 54(1):172-80. PubMed ID: 23030457
[TBL] [Abstract][Full Text] [Related]
3. Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study.
Olesen JB; Hansen PR; Abildstrøm SZ; Andersson C; Weeke P; Schmiegelow M; Erdal J; Torp-Pedersen C; Gislason GH
Pharmacoepidemiol Drug Saf; 2011 Feb; 20(2):146-53. PubMed ID: 21254285
[TBL] [Abstract][Full Text] [Related]
4. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
[TBL] [Abstract][Full Text] [Related]
5. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
[TBL] [Abstract][Full Text] [Related]
6. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
[TBL] [Abstract][Full Text] [Related]
7. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.
Schramm TK; Gislason GH; Vaag A; Rasmussen JN; Folke F; Hansen ML; Fosbøl EL; Køber L; Norgaard ML; Madsen M; Hansen PR; Torp-Pedersen C
Eur Heart J; 2011 Aug; 32(15):1900-8. PubMed ID: 21471135
[TBL] [Abstract][Full Text] [Related]
8. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drugs and risk of suicide: a nationwide study.
Olesen JB; Hansen PR; Erdal J; Abildstrøm SZ; Weeke P; Fosbøl EL; Poulsen HE; Gislason GH
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):518-24. PubMed ID: 20235081
[TBL] [Abstract][Full Text] [Related]
10. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort.
Lhatoo SD; Johnson AL; Goodridge DM; MacDonald BK; Sander JW; Shorvon SD
Ann Neurol; 2001 Mar; 49(3):336-44. PubMed ID: 11261508
[TBL] [Abstract][Full Text] [Related]
11. National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use.
Abraham NS; Castillo DL; Hartman C
Aliment Pharmacol Ther; 2008 Jul; 28(1):97-106. PubMed ID: 18397385
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
Meisinger C; Döring A; Löwel H;
Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.
Artama M; Auvinen A; Raudaskoski T; Isojärvi I; Isojärvi J
Neurology; 2005 Jun; 64(11):1874-8. PubMed ID: 15955936
[TBL] [Abstract][Full Text] [Related]
14. Fracture risk associated with use of antiepileptic drugs.
Vestergaard P; Rejnmark L; Mosekilde L
Epilepsia; 2004 Nov; 45(11):1330-7. PubMed ID: 15509233
[TBL] [Abstract][Full Text] [Related]
15. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
[TBL] [Abstract][Full Text] [Related]
16. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
17. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
Shah AM; Pfeffer MA; Hartley LH; Moyé LA; Gersh BJ; Rutherford JD; Lamas GA; Rouleau JL; Braunwald E; Solomon SD
Am J Cardiol; 2010 Oct; 106(7):911-6. PubMed ID: 20854949
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
19. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
20. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
